Your browser doesn't support javascript.
loading
Prevalence and characterization of hepatitis B and C virus infections in a needle-sharing population in Northern China.
Xu, Cheng-Jun; Zhang, Cui-Ping; Luo, Bi-Fen; Liu, Li-Jun; Wang, Yun-Zhong; Wang, Xiao-Hong; He, Qiu-Jie; Zhou, Shan-Shan; Guo, Wei-Shan; Wang, Jiu-Heng; Yang, Rui-Feng; Zhang, Hai-Ying; Rao, Hui-Ying; Feng, Bo; Wei, Lai.
Afiliación
  • Xu CJ; Department of Infectious Diseases, People's Hospital of Kuancheng Manchu Nationality Autonomous County, Hebei, 067600, China. xcj123321@163.com.
  • Zhang CP; Department of Infectious Diseases, People's Hospital of Kuancheng Manchu Nationality Autonomous County, Hebei, 067600, China. zhcp.1979@163.com.
  • Luo BF; Peking University People's Hospital, Peking University Hepatology Institute, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, No. 11 Xizhimen South Street, Beijing, 100044, China. luobifen@qq.com.
  • Liu LJ; Department of Infectious Diseases, People's Hospital of Kuancheng Manchu Nationality Autonomous County, Hebei, 067600, China. 986224066@qq.com.
  • Wang YZ; Department of Infectious Diseases, People's Hospital of Kuancheng Manchu Nationality Autonomous County, Hebei, 067600, China. wyz18831419811@163.com.
  • Wang XH; Department of Infectious Diseases, People's Hospital of Kuancheng Manchu Nationality Autonomous County, Hebei, 067600, China. 1214738844@qq.com.
  • He QJ; Department of Infectious Diseases, People's Hospital of Kuancheng Manchu Nationality Autonomous County, Hebei, 067600, China. heqiujie666@163.com.
  • Zhou SS; Department of Infectious Diseases, People's Hospital of Kuancheng Manchu Nationality Autonomous County, Hebei, 067600, China. 639818719@qq.com.
  • Guo WS; Department of Infectious Diseases, People's Hospital of Kuancheng Manchu Nationality Autonomous County, Hebei, 067600, China. xyy6632526@163.com.
  • Wang JH; Department of Infectious Diseases, People's Hospital of Kuancheng Manchu Nationality Autonomous County, Hebei, 067600, China. 281630718@qq.com.
  • Yang RF; Peking University People's Hospital, Peking University Hepatology Institute, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, No. 11 Xizhimen South Street, Beijing, 100044, China. yangruifeng103@live.cn.
  • Zhang HY; Peking University People's Hospital, Peking University Hepatology Institute, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, No. 11 Xizhimen South Street, Beijing, 100044, China. zhanghaiying_zhy@163.com.
  • Rao HY; Peking University People's Hospital, Peking University Hepatology Institute, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, No. 11 Xizhimen South Street, Beijing, 100044, China. rao.huiying@163.com.
  • Feng B; Peking University People's Hospital, Peking University Hepatology Institute, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, No. 11 Xizhimen South Street, Beijing, 100044, China. xyfyfb_1@sina.com.
  • Wei L; Peking University People's Hospital, Peking University Hepatology Institute, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, No. 11 Xizhimen South Street, Beijing, 100044, China. weilai@pkuph.edu.cn.
BMC Public Health ; 15: 460, 2015 May 02.
Article en En | MEDLINE | ID: mdl-25933922
BACKGROUND: The epidemiologies of hepatitis C virus (HCV) and hepatitis B virus (HBV) infections in specific populations in certain areas of China are poorly understood. A pilot survey of HCV/HBV infections was carried out in villages in Kuancheng County, Heben Province, where injection of sodium benzoate or amphetamines using shared needles has been a common practice. The aims of this study were to analyze the endemicity and characterize HCV/HBV infections in this population. METHODS: Data on demographic characteristics and drug abuse were collected from individuals who signed informed consent forms. Serum HCV antibody (anti-HCV), hepatitis B surface antigen (HBsAg), and hepatitis B core antibody (anti-HBc) were measured in all participants. HCV RNA was measured in samples positive for anti-HCV using real-time polymerase chain reaction. RESULTS: Among 852 participants from 11 villages, 49.9% had used sodium benzoate or amphetamine at least once, by intravenous injection. The overall prevalence of anti-HCV, HCV RNA, anti-HBc, HBsAg, and HCV/HBV co-infection was 37.1%, 26.6%, 67.7%, 10.7%, and 30.0%, respectively. Two-hundred-twenty-three of 227 (98.2%) participants positive for HCV RNA were aged >40 years. Co-infection was related to sex, age, number of injections, and time from first injection. The rate of spontaneous HCV RNA clearance was 28.2% (89/316), and was related to the number of injections, time from first injection, and HBsAg positivity. However, HBsAg was related to the anti-HBc signal/cut-off ratio rather than to the above parameters. Trend tests demonstrated that the prevalence of anti-HCV, HCV RNA, and anti-HBc was related to the number of injections (P < 0.001), while HBsAg prevalence was not (P = 0.347). CONCLUSIONS: The prevalence of HCV and HBV infection is likely to be high among individuals older than 40 years in areas of needle sharing, and one-time screening for HCV infection should be offered to these populations.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Compartición de Agujas / Hepatitis C / Hepatitis B Tipo de estudio: Prevalence_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: BMC Public Health Asunto de la revista: SAUDE PUBLICA Año: 2015 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Compartición de Agujas / Hepatitis C / Hepatitis B Tipo de estudio: Prevalence_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: BMC Public Health Asunto de la revista: SAUDE PUBLICA Año: 2015 Tipo del documento: Article País de afiliación: China